Regeneron Buys 23andMe in Bankruptcy Auction

1. Regeneron to purchase 23andMe for $256 million in bankruptcy auction. 2. The acquisition supports 23andMe's continued DNA testing services post-bankruptcy. 3. Regeneron aims to enhance genetic research through this acquisition. 4. Deal expected to close in Q3, pending approvals. 5. Recent trading shows REGN shares down 0.4% and 17% down for 2025.